2007 | A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status
| BRITISH JOURNAL OF CANCER |
2006 | A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens
| BRITISH JOURNAL OF CANCER |
2014 | A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer.
| BRITISH JOURNAL OF CANCER |
2021 | A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer
| BRITISH JOURNAL OF CANCER |
2012 | Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis
| BRITISH JOURNAL OF CANCER |
2018 | Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: An analysis of the phase 3 REACH study | BRITISH JOURNAL OF CANCER |
2017 | ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer | BRITISH JOURNAL OF CANCER |
2014 | Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients.
| BRITISH JOURNAL OF CANCER |
2020 | Association between the National Cancer Screening Programme (NSCP) for gastric cancer and oesophageal cancer mortality
| BRITISH JOURNAL OF CANCER |
2009 | DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers
| BRITISH JOURNAL OF CANCER |
2016 | Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers | BRITISH JOURNAL OF CANCER |
2018 | Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: Pooled analyses after long-term follow-up in KEYNOTE-012 | BRITISH JOURNAL OF CANCER |
2008 | ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
| BRITISH JOURNAL OF CANCER |
2013 | Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis
| BRITISH JOURNAL OF CANCER |
2014 | First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.
| BRITISH JOURNAL OF CANCER |
2007 | Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease
| BRITISH JOURNAL OF CANCER |
2020 | Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response
| BRITISH JOURNAL OF CANCER |
2020 | Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck
| BRITISH JOURNAL OF CANCER |
2018 | Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma | BRITISH JOURNAL OF CANCER |
2020 | Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
| BRITISH JOURNAL OF CANCER |
2021 | Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression
| BRITISH JOURNAL OF CANCER |
2021 | Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer
| BRITISH JOURNAL OF CANCER |
2008 | Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer
| BRITISH JOURNAL OF CANCER |